1. Home
  2. PDSB vs BLNK Comparison

PDSB vs BLNK Comparison

Compare PDSB & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • BLNK
  • Stock Information
  • Founded
  • PDSB 2005
  • BLNK 2009
  • Country
  • PDSB United States
  • BLNK United States
  • Employees
  • PDSB N/A
  • BLNK N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • BLNK Industrial Specialties
  • Sector
  • PDSB Health Care
  • BLNK Consumer Discretionary
  • Exchange
  • PDSB Nasdaq
  • BLNK Nasdaq
  • Market Cap
  • PDSB 72.2M
  • BLNK 77.3M
  • IPO Year
  • PDSB N/A
  • BLNK N/A
  • Fundamental
  • Price
  • PDSB $1.35
  • BLNK $0.97
  • Analyst Decision
  • PDSB Strong Buy
  • BLNK Buy
  • Analyst Count
  • PDSB 2
  • BLNK 8
  • Target Price
  • PDSB $10.00
  • BLNK $2.61
  • AVG Volume (30 Days)
  • PDSB 516.6K
  • BLNK 4.3M
  • Earning Date
  • PDSB 08-12-2025
  • BLNK 08-06-2025
  • Dividend Yield
  • PDSB N/A
  • BLNK N/A
  • EPS Growth
  • PDSB N/A
  • BLNK N/A
  • EPS
  • PDSB N/A
  • BLNK N/A
  • Revenue
  • PDSB N/A
  • BLNK $109,383,000.00
  • Revenue This Year
  • PDSB N/A
  • BLNK N/A
  • Revenue Next Year
  • PDSB N/A
  • BLNK $31.15
  • P/E Ratio
  • PDSB N/A
  • BLNK N/A
  • Revenue Growth
  • PDSB N/A
  • BLNK N/A
  • 52 Week Low
  • PDSB $0.85
  • BLNK $0.63
  • 52 Week High
  • PDSB $4.42
  • BLNK $3.75
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 41.32
  • BLNK 57.30
  • Support Level
  • PDSB $1.18
  • BLNK $0.86
  • Resistance Level
  • PDSB $1.66
  • BLNK $0.98
  • Average True Range (ATR)
  • PDSB 0.11
  • BLNK 0.08
  • MACD
  • PDSB -0.05
  • BLNK 0.00
  • Stochastic Oscillator
  • PDSB 22.42
  • BLNK 65.92

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

Share on Social Networks: